Tenderwize
Wróć do wyszukiwania

Framework agreement for Aflibercept supply

AZ Sint-Lucas vzw·Brugge, Belgium·EUR 5.8M·Expired · Jul 31, 2026·Open·Supplies·Framework
High valueStructured notice only
Oryginalny tytuł ogłoszenia

Belgium – Various medicinal products – Raamovereenkomst voor de levering van Aflibercept

65/100

Ocena szansy

Needs reviewMedium complexity
SuppliesFrameworkExpired
Skąd ta ocena?

Szansa

65 / 100

Złożoność

60 / 100

Czynniki ryzyka

Lot 1 requires Creditsafe score A, B, or C. Bidders without a good financial score will be excluded. The buyer checks t...

Lot 2 requires a valid FAGG license for distribution. Bidders without this license cannot bid on Lot 2.

Głęboka analiza portfolio

Głęboka analiza dopasowania firmy

Wykorzystuje:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Najważniejsze informacje

Zamawiający
AZ Sint-Lucas vzw
Kraj
Belgia
CPV
33690000 - Various medicinal products
Termin
Jul 31, 2026
Szacowana wartość
EUR 5.8M

Przegląd

Moderate opportunity

Kluczowe fakty

  • EUR 5.8M estimated value
  • Framework procurement
  • Supplies contract
  • 3 lots
  • Duration until Sep 2030
  • Supply of Aflibercept (40mg/1ml) medicinal products in two forms: prefilled syringes and vials.
  • Three lots corresponding to different product forms and therapeutic indications.
Pokaż pełne podsumowanie

This is an open tender from AZ Sint-Lucas vzw in Belgium for the supply of Aflibercept (40mg/1ml) medicinal product. It is divided into three lots: Lot 1 covers prefilled syringes for multiple ophthalmic indications, Lot 2 covers prefilled syringes for retinopathy of prematurity (ROP), and Lot 3 covers vials. Each lot is a framework agreement with a 2-year initial term and two silent 1-year extensions. The total maximum framework value across all lots is EUR 5,803,284 (from XML notice). Award is based primarily on price (82-87%) with quality subcriteria. Electronic submission is required through publicprocurement.be. The tender language is Dutch only. Key risks include short submission window, strict eligibility criteria (financial standing, FAGG license, ESPD), and potential inconsistencies in EU funding status. Procurement documents were not analyzed.

Ryzyka

Lot 1 requires Creditsafe score A, B, or C. Bidders without a good financial score will be excluded. The buyer checks t...

Lot 2 requires a valid FAGG license for distribution. Bidders without this license cannot bid on Lot 2.

Analiza może być niepełna

Przeanalizowano tylko część dokumentacji. Pozostałe dokumenty mogą zawierać dodatkowe wymagania, certyfikaty lub dokumenty do złożenia.

Kluczowe wymagania

Administrative

  • Submission language: Dutch only.
  • Electronic submission via publicprocurement.be is mandatory.
  • Bidders can submit for up to 3 lots.

Wymagania mogą być niepełne.

Kryteria udzielenia

Lot 1

Price (82%) — 82%Flexibility of storage conditions (8%) — 8%Ease of use and safety (5%) — 5%Production place (5%) — 5%

Lot 2

Price (82%) — 82%Flexibility of storage conditions (8%) — 8%Ease of use and safety (5%) — 5%Production place (5%) — 5%

Lot 3

Price (87%) — 87%Flexibility of storage conditions (8%) — 8%Production place (5%) — 5%

Zamawiający

Lokalizacja

Brugge, BEL

Profil zamawiającego

Otwórz profil

Identyfikator

408.116.216

Działalność

Health

Części (3)

LOT-0001

Aflibercept Pre-filled Syringe – Multiple Indications

Supply of Aflibercept (40mg/1ml) prefilled syringe registered for: neovascular age-related macular degeneration, visual impairment due to macular edema secondary to retinal vein occlusion, diabetic macular edema, and myopic choroidal neovascularization.

SuppliesFrameworkEU fundedElectronic submission

EUR 5.7M

Szacowana wartość

Lokalizacja

Brugge, Belgium

Czas trwania

Sep 2026 - Sep 2030

Kategoria

Medicinal products

Kryteria udzielenia

Price

Termin

Expired Jul 31, 2026

LOT-0002

Aflibercept Pre-filled Syringe – ROP

Supply of Aflibercept (40mg/1ml) prefilled syringe registered for the treatment of retinopathy of prematurity (ROP).

SuppliesFrameworkEU fundedElectronic submission

EUR 8.5k

Szacowana wartość

Lokalizacja

Brugge, Belgium

Czas trwania

Sep 2026 - Sep 2030

Kategoria

Medicinal products

Kryteria udzielenia

Price

Termin

Expired Jul 31, 2026

LOT-0003

Aflibercept Vial

Supply of Aflibercept (40mg/1ml) in vial form.

SuppliesFrameworkEU fundedElectronic submission

EUR 98.4k

Szacowana wartość

Lokalizacja

Brugge, Belgium

Czas trwania

Sep 2026 - Sep 2030

Kategoria

Medicinal products

Kryteria udzielenia

Price

Termin

Expired Jul 31, 2026

Szczegóły zamówienia

Data publikacji
01 Jul 2026
Języki
Dutch

Metadane referencyjne

Podstawa prawna
32014L0024

Identyfikatory referencyjne

ID przetargu
455937-2026

Dokumenty (2)

Podobne przetargi